Name: Jamie Haugen
Age: 27
Hometown: Shelby Township, MI
Link: https://endurance.themmrf.org/2018EverestBaseCamp/jamieandmike

Mike and I are so excited and humbled to be a part of this Everest Base Camp team. Our purpose on this journey is to raise funds for research all while raising awareness for the MMRF and multiple myeloma along the way.

Our connection to this disease stems from my family member, who was diagnosed with multiple myeloma after going to the hospital for back pain eight years ago. A tumor was found wrapped around his spine and he received emergency surgery performed by the amazing surgeons at the University of Florida Hospital. After re-learning how to walk, and amazing all-medical staff around him, he has told cancer to take a seat and continued to be the strongest man I know. His resilience is fierce, much like the researchers and founder of the MMRF, who have made incredible strides in the treatment of multiple myeloma.

My first experience with the MMRF was in 2012, when my brother and I had the opportunity to join the MMRF in the Empire State Building Run-Up. Ever since then, I have wanted to participate in another event and give back in a large way. When I saw Moving Mountains for Multiple Myeloma, I knew I wanted to get involved. Mike did not hesitate to join me in this quest and I must say, we make a great team.

Name: Michael Harr
Age: 29 
Hometown: Shelby Township, MI
Link: https://endurance.themmrf.org/2018EverestBaseCamp/jamieandmike

I am so excited to be doing this event along with Jamie. It means a great deal to me to be able to have a direct impact on medical research that could one day prevent this awful disease. Having witnessed some of the hardships experienced by myeloma patients and the rippling effects through the supporting family, I will strive to raise as much awareness (and donations!) as possible for this awesome foundation.

We are so looking forward to the challenges and triumphs ahead of us in this journey and we are so thankful for the MMRF for being a catalyst of progression in cancer research. Let's do this, team.